Who we are

ICARSIS is a Health Informatics company established in 2006. We work with the NHS and specialized research groups throughout the UK. Our expertise is in building Disease-Specific Information Systems from which we analyse and deliver health informatics. Working with the leading founding Trusts throughout the UK as well as academic institutions in clinical and translational research.

Disease-Specific Information Systems

We’ve developed disease specific medical database to enable translational research through the NHS. We have a wide range of experience working across many medical specialities.

We have developed systems for the following areas of medicine:

  • Cutaneous Lymphoma
  • Melanoma
  • Non Melanoma Skin Cancer
  • Prostate Cancer
  • Graft vs. Host Disease
  • Vitiligo
  • Tissue Banking
  • Skin Genetics
  • Xeroderma Pigmentosum (XP)

Melanoma Project

The Melanoma Project was set up to improve data collection for melanoma and other skin cancers. Each Hospital Trust participating in the project will collect a wide range of standardised data – both current and historical – about their patients. This can then be interrogated and used for the benefit of their skin cancer service.


Journal of Clinical Oncology

Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal.

European Journal of Cancer

A Cutaneous Lymphoma International Prognostic Index (CLIPi) for Mycosis Fungoides and Sezary Syndrome.

Bone Marrow Transplantation

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.


Positive Effect of Extracorporeal Photopheresis In Reducing Immunosuppression in Patients with Chronic Graft Versus Host Disease.